MARKET

PRPH

PRPH

Prophase Lab
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.82
+0.10
+1.23%
Opening 13:51 02/26 EST
OPEN
7.79
PREV CLOSE
7.72
HIGH
8.00
LOW
7.43
VOLUME
56.84K
TURNOVER
--
52 WEEK HIGH
16.04
52 WEEK LOW
1.200
MARKET CAP
118.43M
P/E (TTM)
-52.1696
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Analysts Expect ProPhase Labs, Inc. (NASDAQ:PRPH) To Breakeven Soon
We feel now is a pretty good time to analyse ProPhase Labs, Inc.'s ( NASDAQ:PRPH ) business as it appears the company...
Simply Wall St. · 02/17 12:06
Oral Spray Market 2021 : Market Size, Growth, Top Countries Data with Overview and Geographical Forecast Till 2026
The Express Wire · 02/11 01:19
ProPhase Labs Begins Advanced, Saliva-based Viral PCR Multiplex-Testing For COVID-19, Influenza A & B, And Other Viruses After FDA Confirmation Of Two Emergency Use Authorizations
Company Integrates Spectrum Solutions™ SDNA-1000 Saliva Collection System for Advanced, Simultaneous Multi-Viral Detection of Infections and Viral Mutations GARDEN CITY, NY, Feb. 09, 2021 (GLOBE NEWSWIRE)
Benzinga · 02/09 13:31
ProPhase Labs Receives FDA Approval and Launches Testing for COVID-19, Influenza A & B, and Other Viruses
MT Newswires · 02/09 09:55
Global Oral Spray Market Growth Analysis Report 2021: Global Industry Size, Market Demand and Forthcoming Development, Current Trends, Top Companies Research Forecast to 2027
Feb 09, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." The “Oral Spray Market” report delivers...
The Express Wire · 02/09 09:43
Seeking Alpha Catalyst Watch
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a
Seekingalpha · 02/05 20:30
8-K: ProPhase Labs, Inc.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 02/01 23:06
DJ ProPhase Labs Shares Rise 12% on Covid-19 Testing Goals
Dow Jones · 02/01 18:08
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PRPH. Analyze the recent business situations of Prophase Lab through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PRPH stock price target is 22.50 with a high estimate of 25.00 and a low estimate of 20.00.
EPS
Institutional Holdings
Institutions: 26
Institutional Holdings: 513.22K
% Owned: 3.39%
Shares Outstanding: 15.15M
TypeInstitutionsShares
Increased
6
85.78K
New
8
18.10K
Decreased
2
96.00K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Food Processing
-0.96%
Food & Tobacco
-1.00%
Key Executives
Chairman/Chief Executive Officer/Director
Ted Karkus
Chief Financial Officer
Monica Brady
Independent Director
Jason Barr
Independent Director
Louis Gleckel
Independent Director
Warren Hirsch
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
11/20/2019
Dividend USD 0.25
12/02/2019
12/26/2018
Dividend USD 0
01/09/2019
12/26/2018
Special Dividend USD 0.25
01/09/2019
05/07/2018
Dividend USD 0
06/06/2018
05/07/2018
Special Dividend USD 1
06/06/2018
About PRPH
ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK Supplements and ORXx Complete. TK Supplements consists of LEGENDZ XL, a male sexual enhancement; TRIPLE EDGE XL, a daily energy and stamina booster, and SUPER PROSTAFLOW plus, a supplement to support prostate and urinary health. The Company's OTC offerings include the ORXx cough/cold drops. Its consumer health customers include national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies.

Webull offers kinds of ProPhase Labs Inc stock information, including NASDAQ:PRPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRPH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRPH stock methods without spending real money on the virtual paper trading platform.